What to expect when you take Midodrine hydrochloride and have Systemic lupus erythematosus?

Do you take Midodrine hydrochloride and have Systemic lupus erythematosus? Find out below what new side effects and undetected conditions people who are 50-59 years old may have. This prediction is created after we perform predictive analysis on health care big data. It will be updated regularly.

To personalize this prediction to you, including to your gender, age, personal and family history, and more: Click here



On Jun, 20, 2018

611 reports have been studied.


Females aged 50 to 59 :

391 related reports were analyzed:

Most common symptoms:

Abasia (inability to walk)
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Anaemia (lack of blood)
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Appetite - decreased (decreased appetite occurs when you have a reduced desire to eat)
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Atrial fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles)
  • 9.97% for females aged 50 (±5) who take Midodrine hydrochloride
Bleeding disorders
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Bone disorder
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Cardiac failure congestive
  • 6.65% for females aged 50 (±5) who take Midodrine hydrochloride
Cellulitis (infection under the skin)
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Deformity (disfigurement)
  • 11.76% for females aged 50 (±5) who take Midodrine hydrochloride
Depression
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Diarrhea
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Dizziness
  • 10.49% for females aged 50 (±5) who take Midodrine hydrochloride
Dyspnea (difficult or laboured breathing)
  • 10.49% for females aged 50 (±5) who take Midodrine hydrochloride
Dyspnea exertional
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Ejection fraction decreased (systolic heart failure)
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Enlarged heart
  • 6.65% for females aged 50 (±5) who take Midodrine hydrochloride
Fall
  • 8.18% for females aged 50 (±5) who take Midodrine hydrochloride
Fatigue (feeling of tiredness)
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Fibrosis (formation of excess fibrous connective tissue in an organ or tissue)
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Gait disturbance
  • 10.23% for females aged 50 (±5) who take Midodrine hydrochloride
General physical health deterioration (weak health status)
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Headache (pain in head)
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Hearing loss
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
High blood pressure
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Hypoaesthesia (reduced sense of touch or sensation)
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Hypotension (abnormally low blood pressure)
  • 11.76% for females aged 50 (±5) who take Midodrine hydrochloride
Indigestion
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Infection
  • 9.21% for females aged 50 (±5) who take Midodrine hydrochloride
Injury
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Jaw fracture
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Joint dislocation (a joint position is changed from normal position)
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Joint pain
  • 12.28% for females aged 50 (±5) who take Midodrine hydrochloride
Joint range of motion decreased (disease of joint movement)
  • 7.42% for females aged 50 (±5) who take Midodrine hydrochloride
Joint stiffness
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Mobility decreased (ability to move is reduced)
  • 15.6% for females aged 50 (±5) who take Midodrine hydrochloride
Musculoskeletal stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves)
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Nausea (feeling of having an urge to vomit)
  • 11.25% for females aged 50 (±5) who take Midodrine hydrochloride
Neck pain
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • 13.55% for females aged 50 (±5) who take Midodrine hydrochloride
Neuropathy peripheral (surface nerve damage)
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Oedema (fluid collection in tissue)
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Oedema peripheral (superficial swelling)
  • 14.83% for females aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Osteonecrosis of jaw (death of bone of jaw)
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 23.02% for females aged 50 (±5) who take Midodrine hydrochloride
Pain in extremity
  • 14.58% for females aged 50 (±5) who take Midodrine hydrochloride
Pain in jaw
  • 5.63% for females aged 50 (±5) who take Midodrine hydrochloride
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Pleural effusion (water on the lungs)
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary congestion (congestion in the lungs)
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary hypertension (increase in blood pressure in the lung artery)
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Pulmonary oedema (fluid accumulation in the lungs)
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Rashes (redness)
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Renal failure chronic (long lasting kidney dysfunction)
  • 10.23% for females aged 50 (±5) who take Midodrine hydrochloride
Scar
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Skin burning sensation
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Skin exfoliation (removal of the oldest dead skin cells)
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Skin fibrosis (fibrous tissue formation on skin)
  • 8.95% for females aged 50 (±5) who take Midodrine hydrochloride
Skin hyperpigmentation (disorders affect the colour of your skin)
  • 11.0% for females aged 50 (±5) who take Midodrine hydrochloride
Skin hypertrophy (skin cells enlarges)
  • 9.72% for females aged 50 (±5) who take Midodrine hydrochloride
Skin induration (an abnormally hard spot or area on the skin)
  • 10.74% for females aged 50 (±5) who take Midodrine hydrochloride
Skin plaque (red, scaly patches to appear on the skin)
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Skin tightness
  • 9.46% for females aged 50 (±5) who take Midodrine hydrochloride
Spinal compression fracture (fracture due to spinal compression on bone)
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 11.0% for females aged 50 (±5) who take Midodrine hydrochloride
Swallowing difficulty
  • 9.21% for females aged 50 (±5) who take Midodrine hydrochloride
Thrombocytopenia (decrease of platelets in blood)
  • 5.12% for females aged 50 (±5) who take Midodrine hydrochloride
Tooth abscess (pus formation in tooth)
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Urinary tract infection
  • 7.67% for females aged 50 (±5) who take Midodrine hydrochloride
Weakness
  • 18.67% for females aged 50 (±5) who take Midodrine hydrochloride
Weight decreased
  • 11.51% for females aged 50 (±5) who take Midodrine hydrochloride

Most common co-existing conditions:

Depression
  • 7.93% for females aged 50 (±5) who take Midodrine hydrochloride
High blood cholesterol
  • 5.88% for females aged 50 (±5) who take Midodrine hydrochloride
Related Tests
Multiple myeloma (cancer of the plasma cells)
  • 7.93% for females aged 50 (±5) who take Midodrine hydrochloride
Nuclear magnetic resonance imaging brain
  • 7.16% for females aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  • 6.39% for females aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 8.7% for females aged 50 (±5) who take Midodrine hydrochloride
Primary pulmonary hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart)
  • 5.37% for females aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 6.14% for females aged 50 (±5) who take Midodrine hydrochloride
back to top

Males aged 50 to 59 :

220 related reports were analyzed:

Most common symptoms:

Acute kidney failure
  • 8.64% for males aged 50 (±5) who take Midodrine hydrochloride
Arrhythmias (irregular heartbeat)
  • 7.73% for males aged 50 (±5) who take Midodrine hydrochloride
Cardiac failure congestive
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Cardio-respiratory arrest (sudden dysfunction of heart and lungs)
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Chest pain
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Diarrhea
  • 8.18% for males aged 50 (±5) who take Midodrine hydrochloride
Dizziness
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Dyspnea (difficult or laboured breathing)
  • 10.91% for males aged 50 (±5) who take Midodrine hydrochloride
Fall
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Fatigue (feeling of tiredness)
  • 7.27% for males aged 50 (±5) who take Midodrine hydrochloride
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  • 7.73% for males aged 50 (±5) who take Midodrine hydrochloride
Headache (pain in head)
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Hepatic failure (liver failure)
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
High blood pressure
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Hypotension (abnormally low blood pressure)
  • 16.82% for males aged 50 (±5) who take Midodrine hydrochloride
Nausea (feeling of having an urge to vomit)
  • 9.55% for males aged 50 (±5) who take Midodrine hydrochloride
Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 6.36% for males aged 50 (±5) who take Midodrine hydrochloride
Pneumonia
  • 10.45% for males aged 50 (±5) who take Midodrine hydrochloride
Renal failure acute (rapid kidney dysfunction)
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Sepsis (a severe blood infection that can lead to organ failure and death)
  • 7.27% for males aged 50 (±5) who take Midodrine hydrochloride
Septic shock (shock due to blood infection)
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Stress and anxiety
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Thrombocytopenia (decrease of platelets in blood)
  • 5.91% for males aged 50 (±5) who take Midodrine hydrochloride
Weakness
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride

Most common co-existing conditions:

Multiple myeloma (cancer of the plasma cells)
  • 6.36% for males aged 50 (±5) who take Midodrine hydrochloride
Nuclear magnetic resonance imaging brain
  • 5.45% for males aged 50 (±5) who take Midodrine hydrochloride
Orthostatic hypotension (a medical condition consisting of a sudden decrease in blood pressure when a person stands up)
  • 5.0% for males aged 50 (±5) who take Midodrine hydrochloride
Pain
  • 6.82% for males aged 50 (±5) who take Midodrine hydrochloride
back to top

Related studies

midodrine hydrochloride

Midodrine hydrochloride has active ingredients of midodrine hydrochloride. It is often used in hypotension. (latest outcomes from Midodrine hydrochloride 1,200 users)

systemic lupus erythematosus

Systemic lupus erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue) has been reported by people with rheumatoid arthritis, systemic lupus erythematosus, crohn's disease, multiple sclerosis, osteoporosis (latest reports from 25,871 Systemic lupus erythematosus patients).

Midodrine hydrochloride and Systemic lupus erythematosus

Related publications that referenced our studies


Analysis tools (to study 615 million drug outcomes from FDA)

  • Check symptoms - identify the cause of a symptom: from a drug or from a condition?
  • Check drugs - find out common side effects or drug interactions of my drugs.
  • Compare drugs - compare the side effects and efficacy of multiple drugs side by side.

You are not alone. Join our personalized support groups:

You may be interested in these posts

More posts for: Midodrine hydrochloride, Systemic lupus erythematosus

Recent updates

General studies
Active Support Groups
Recent Predictions
Personalized studies

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on ePatient.care is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the ePatient.care site and its content is at your own risk.